For The Better

Last week, the U.S. Food and Drug Administration (FDA) approved Guardant Health’s Shield™ blood test as a primary screening option for colorectal cancer (CRC) in adults aged 45 and older, marking a pivotal advance in the realm of cancer diagnostics. Ai…

Last week, the U.S. Food and Drug Administration (FDA) approved Guardant Health’s Shield™ blood test as a primary screening option for colorectal cancer (CRC) in adults aged 45 and older, marking a pivotal advance in the realm of cancer diagnostics. Ai…

Kinder Morgan’s investment thesis is noticeably improving in the age of AI.

From smaller companies chock-full of potential to proven passive-income powerhouses, there are plenty of growth, dividend, and value stocks to buy this month.

Learn the hidden AI play that billionaires can’t get enough of.

These stocks pay between 3.3% and 6.6% in dividends and trade at low earnings multiples.

Public Storage has been buying back its attractively valued stock.

Brookfield Infrastructure offers investors the best of both worlds.

The next few quarters will clearly be rough for Mobileye. But after that?

Sometimes figuring out the better buy comes down to an investor’s risk tolerance.

These companies stocks dipped in July, presenting compelling investment opportunities.

The market will be closely watching this high-stakes earnings report.

The company’s recent earnings were far more impressive than its 9% revenue growth implies.

These outstanding businesses are worth buying hand over fist right now.

ExxonMobil is the undisputed leader in big oil.

Learn how $500 a month can grow into a sizable nest egg.

Elon Musk had some frank words for investors during the second-quarter earnings call.

While Bitcoin has disappointed investors in the first half of the year, a new rally could be coming soon.